COVID-19/SARS-CoV-2

Articles (8 in this collection)

1. Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management

   Authors

   • Alexander H. Williams
   • Chang-Guo Zhan

   • Content type: Review Article
   • Published: 18 July 2023

   • Pages: 649 - 674

   

2. Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy

   Authors (first, second and last of 10)

   • Francesco Ciccimarra
   • Nicoletta Luxi
   • Gianluca Trifirò

   • Content type: Original Research Article
   • Open Access
   • Published: 06 May 2023

   • Pages: 675 - 684

   

3. Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)

   Authors (first, second and last of 15)

   • Joaquín Sáez-Peñataro
   • Ferran Torres
   • the VigilVacCOVID Group

   • Content type: Original Research Article
   • Open Access
   • Published: 28 June 2022

   • Pages: 509 - 520

4. Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management

   Authors (first, second and last of 15)

   • Nicoletta Luxi
   • Alexia Giovanazzi
   • Gianluca Trifirò

   • Content type: Review Article
   • Open Access
   • Published: 13 June 2022

   • Pages: 443 - 458

5. Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

   Authors (first, second and last of 6)

   • William R. Strohl
   • Zhiqiang Ku
   • Lila M. Strohl

   • Content type: Leading Article
   • Open Access
   • Published: 27 April 2022

   • Pages: 231 - 323

   

6. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin

   Authors (first, second and last of 6)

   • Andreas Volk
   • Caroline Covini-Souris
   • Torben Schmidt

   • Content type: Original Research Article
   • Open Access
   • Published: 29 November 2021

   • Pages: 41 - 53

   

7. Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?

   Authors

   • Shubham Atal
   • Zeenat Fatima
   • Sadasivam Balakrishnan

   • Content type: Current Opinion
   • Published: 13 October 2020

   • Pages: 705 - 711

8. Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks

   Authors (first, second and last of 5)

   • Salvatore Crisafulli
   • Valentina Isgrò
   • Gianluca Trifirò

   • Content type: Leading Article
   • Published: 15 June 2020

   • Pages: 415 - 422